🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Drug-eluting Stent

Comparison of a Contemporary Sirolimus-eluting Stent (ihtDEStiny®) With Another Everolimus-eluting Stent (Xience™), Both With Permanent Polymers, in Patients With Acute Coronary Syndrome and de Novo Coronary Artery Lesions NCT07190690NA20 sites📍 Alicante📍 Badalona📍 Barakaldo Fundación EPIC · Tests: ihtDEStiny® DES implanted, Xience™ DES implanted Efficacy and Safety of Fully Resorbable Sinus Drug-eluting Stents in Patients With Eosinophilic Chronic Rhinosinusitis With Nasal Polyps After Surgery: A Prospective, Randomized Controlled Trial NCT07498374NA1 site📍 Xi'an Tang-Du Hospital · Tests: the fully degradable sinus stent, intranasal corticosteroids, oral corticosteroids BASel Kosten-Effektivitäts-Trial: Drug-coated BALLoon (DCB) vs. Drug-eluting Stent (DES) Strategy in High-risk Patients With Coronary Artery Disease (CAD) NCT07363161NA3 sites📍 Homburg📍 Basel📍 Zurich B. Braun Melsungen AG · Tests: PCI, PCI Drug-eluting Stenting Versus Medical Treatment for Extracranial Vertebral Artery Stenosis NCT05885932NA1 site📍 Beijing Xuanwu Hospital, Beijing · Tests: Drug-eluting stenting plus aspirin and clopidogrel or ticagrelor, Aspirin and clopidogrel or ticagrelor, mono anti-plat… Absorbable Drug-Eluting Lacrimal Sac Stent for Recurrent Chronic Dacryocystitis NCT07499791Phase 22 sites📍 Beijing📍 Beijing Beijing Tongren Hospital · Tests: Absorbable Lacrimal Sac Drug-Eluting Stent, Conventional Ostium Packing with Budesonide Nasal Spray Ultrathin-strut Biodegradable Polymer Sirolimus-eluting Stents With P2Y12 Inhibitor-based Single Antiplatelet Therapy vs. Conventional DAPT for Unprotected Left Main Coronary Artery Disease (ULTIMATE-LM) NCT05650411NA1 site📍 Zurich IGLESIAS Juan Fernando · Tests: LMCA PCI with Supraflex Cruz ultrathin-strut biodegradable polymer sirolimus-eluting stent (Sahajanand Medical Technolo… Drug-Coated Balloon in Anticoagulated and Bleeding Risk Patients Undergoing PCI NCT04814212NA14 sites📍 Jyväskylä📍 Rovaniemi📍 Kuopio North Karelia Central Hospital · Tests: Percutaneous coronary intervention using drug-coated balloon, Percutaneous coronary intervention using drug-eluting ste… Anatomic Versus Physiologic Guidance for Complete Revascularization With DES Eluting in Patients With CAD NCT05529459NA17 sites📍 Anyang📍 Bucheon-si📍 Busan Seung-Whan Lee, M.D., Ph.D. · Tests: Percutaneous Coronary Intervention The PIONEER-IV Study is Comparing Clinical Outcomes Between Angiography-derived Physiology Guidance to Usual Care in an All-comers PCI Population With Unrestrictive Use of the HT Supreme Sirolimus-eluting Stent NCT04923191NA19 sites📍 Aalst📍 Aalst📍 Bonheiden National University of Ireland, Galway, Ireland · Tests: Angiography-derived physiology guidance/Local routine diagnostic procedure (LRDP) and usual care Drug-coated Balloon Treatment NCT07794839n/a1 site📍 Istanbul Istanbul Mehmet Akif Ersoy Educational and Training Hospital · Tests: drug coated balloon, drug eluting stent Late-lumen Changes After Drug-Coated Balloon Angioplasty Versus Drug-Eluting Stents in De Novo Coronary Lesions NCT06954714NA8 sites📍 Busan📍 Daegu📍 Gwangju Chonnam National University Hospital · Tests: Drug-eluting stent implantation, Drug-coated balloon angioplasty Appropriate Duration of Anti-Platelet straTegy in Patients With Advance Chronic Kidney Disease After New Generation Drug Eluting Stents (ADAPT-CKD) NCT04708587NA1 site📍 Seoul Yonsei University · Tests: dual anti-platelet therapy at least 6 months, dual anti-platelet therapy 3months or less Drug Eluting Stenting and Aggressive Medical Treatment for Preventing Recurrent Stroke in Intracranial Atherosclerotic Disease Trial NCT04948749NA18 sites📍 Beijing📍 Beijing📍 Cangzhou Beijing Tiantan Hospital · Tests: Drug Eluting Stent implantation, Aggressive medical treatment, Risk factor management, Standard medical treatment Evaluation of Effectiveness and Safety of Synergy XD and Synergy Megatron™ Stent NCT05044273n/a23 sites📍 Anyang📍 Busan📍 Busan Jung-min Ahn · Tests: Synergy XD stent or Synergy Megatron™ Stent DCB vs. DES in Bifurcation Coronary Lesions NCT06551662NA17 sites📍 Milan📍 Gdansk📍 Katowice Fondazione Ricerca e Innovazione Cardiovascolare ETS · Tests: Paclitaxel drug-coated balloons, Sirolimus drug-coated balloons, New generation drug-eluting stent IVUS-guided DES Implantation in Coronary Calcification NCT05800002NA1 site📍 Nanjing Nanjing First Hospital, Nanjing Medical University · Tests: Intravascular ultrasound, Angiography BioFreedom Ultra Registry NCT05094284n/a1 site📍 Shatin Chinese University of Hong Kong · Tests: BioFreedom Ultra Impact of Stepwise Pressure-Increasing NC Balloon Post-Dilation on Stent Expansion NCT07853261NA1 site📍 Changchun Jilin University · Tests: Coronary stent + non-compliant post-dilation balloon DEBSCAN-IVL. Drug Eluting Balloon or Drug Eluting Stent to Treat CAlcified Nodules After IntraVascular Lithotripsy. NCT06657833NA15 sites📍 Leiden📍 Barcelona📍 Fuencarral-El Pardo Fundación EPIC · Tests: Percutaneous coronary intervention of a calcified nodule with intravascular lithotripsy followed by drug eluting balloo… IndObufen Versus asPirin After Coronary Drug-eluting Stent implantaTION in Elderly Patients With Acute Coronary Syndrome NCT06451198Phase 41 site📍 Shanghai Shanghai Zhongshan Hospital · Tests: Indobufen, Aspirin, Ticagrelor Post-market Registry Study on the Safety and Efficacy of ZENFLEX Pro™ Peripheral Drug-eluting Stent System for Femoropopliteal Artery Lesions NCT07122167NA1 site📍 Chrzanów MDCECRO LLC · Tests: Peripheral Drug-eluting Stent System DCB vs. DES in Young STEMI Patients: The DCB-STEMI Trial NCT07229248Phase 31 site📍 Karachi National Institute of Cardiovascular Diseases, Pakistan · Tests: Drug coated balloon (Prevail; Medtronic Inc.), Drug eluting stent Prospective Evaluation of Drug-Eluting Stents in Routine Clinical Practice (ASAN PCI Registry) NCT01788592n/a1 site📍 Seoul Seung-Jung Park Effectiveness of Interventional Therapy for Non-Flow-Limiting Vulnerable Plaques NCT06855537Phase 41 site📍 Beijing Beijing Anzhen Hospital · Tests: PCI strategy, OMT strategy Tailored Anti-platelet Therapy After DES Implantation in High-risk Patients NCT05936606NA1 site📍 Seoul Yonsei University · Tests: Clopidogrel monotherapy, Tailored anti-platelet therapy Hybrid Percutaneous Coronary Intervention Combining a Bioresorbable Scaffold With Drug-coated Balloons Versus a Conventional Drug-eluting Stent-based Strategy in Patients With Long and Diffuse Coronary Artery Disease NCT06710210NA4 sites📍 Geneva📍 Basel📍 Bern University Hospital, Geneva · Tests: PCI with a bioresorbable scaffold and drug-coated balloon(s), PCI with drug-eluting stent(s) Clinical Outcomes of Drug-Coated Balloons in the Treatment of Patients With Coronary De Novo Chronic Total Occlusion Lesions NCT07463664NA18 sites📍 Beijing📍 Anyang📍 Jiaozuo The First Affiliated Hospital of Zhengzhou University · Tests: DES Implantation, DCB Angioplasty Intravascular Imaging-Guided Versus Angiography- Guided PCI in Patients With DES-ISR NCT07297641n/a1 site📍 Nanjing Nanjing First Hospital, Nanjing Medical University · Tests: percutaneous coronary intervention Bifurcation PCI With a Hybrid Strategy With Drug Eluting Balloons Versus a Stepwise Provisional Two-stent Strategy NCT05731687NA1 site📍 Eindhoven Cathreine BV · Tests: Hybrid DEB approach with drug-eluting balloon, Two-stent strategy Bioresorbable Sirolimus-eluting scaffold in de Novo Coronary Artery Lesions NCT07022587NA1 site📍 Xi'an Xijing Hospital · Tests: Sirolimus-eluting bioresorbable scaffolds, Sirolimus-eluting stents
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy